Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MC2R is a G protein-coupled receptor (GPCR) that plays a critical role in the hypothalamic–pituitary–adrenal (HPA) axis, specifically mediating the effects of adrenocorticotropic hormone (ACTH). It is essential for regulating and maintaining adrenocortical function, particularly steroidogenesis—the production of glucocorticoids in the adrenal cortex. Unlike other melanocortin receptors, MC2R is unique because it binds exclusively to ACTH as its endogenous ligand. MRAP is essential for proper trafficking of MC2R from the endoplasmic reticulum to the cell membrane. Mutations in *MC2R* cause familial glucocorticoid deficiency type 1.
Mediates steroidogenesis via cAMP/PKA pathway after binding with ACTH
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanocortin Type 2 Receptor (MC2R).